$Cardiac metabolism in patients with heart failure with mid-range ejection fraction$

Cardiac metabolism in patients with heart failure with mid-range ejection fraction

Bibliographic Details
Main Authors:	Hundertmark, M, Rodgers, C, Rider, O, Neubauer, S, Mahmod, M
Format:	Conference item
Published:	BMJ Publishing Group 2018

Similar Items

Myocardial Metabolism in Heart Failure with Preserved Ejection Fraction
by: Henry, JA, et al.
Published: (2024)

Intentional weight loss as a novel treatment for heart failure with preserved ejection fraction
by: Hundertmark, MJ, et al.
Published: (2021)

Impaired myocardial energetics limits cardiac functional reserve and leads to exercise-induced pulmonary congestion in heart failure with preserved ejection fraction
by: Burrage, M, et al.
Published: (2021)

Energetic basis for exercise-induced pulmonary congestion in heart failure with preserved ejection fraction
by: Burrage, MK, et al.
Published: (2021)

Cardiac energetics in patients with aortic stenosis and preserved versus reduced ejection fraction
by: Peterzan, MA, et al.
Published: (2020)

Heart failure with preserved ejection fraction
by: Harper, A, et al.
Published: (2018)

Deep learning predicts heart failure with preserved, mid-range, and reduced left ventricular ejection fraction from patient clinical profiles
by: Alkhodari, M, et al.
Published: (2021)

Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials
by: Cleland, J, et al.
Published: (2017)

Response by Peterzan et al to letter regarding article, “Cardiac energetics in patients with aortic stenosis and preserved versus reduced ejection fraction”
by: Peterzan, MA, et al.
Published: (2020)

Myocardial energetic impairment is the basis for reduced cardiac reserve and exercise-induced pulmonary congestion in heart failure with preserved ejection fraction: insights from novel cardiopulmonary magnetic resonance imaging
by: Burrage, MK, et al.
Published: (2021)

Prevalence of heart failure preserved ejection fraction in the community
by: Mahadevan, G, et al.
Published: (2007)

The interplay between metabolic alterations, diastolic strain rate and exercise capacity in mild heart failure with preserved ejection fraction: a cardiovascular magnetic resonance study
by: Mahmod, M, et al.
Published: (2018)

Device-Based Solutions to Improve Cardiac Physiology and Hemodynamics in Heart Failure With Preserved Ejection Fraction
by: Rosalia, Luca, et al.
Published: (2022)

Design and rationale of the EMPA-VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure
by: Hundertmark, MJ, et al.
Published: (2021)

Assessment of cardiac energy metabolism, function, and physiology in patients with heart failure taking empagliflozin: the randomized, controlled EMPA-VISION trial
by: Hundertmark, MJ, et al.
Published: (2023)

Response to letter regarding article, "The effect of selective heart rate slowing in heart failure with preserved ejection fraction"
by: Pal, N, et al.
Published: (2016)

Diagnosis of patients with heart failure with preserved ejection fraction in primary care: cohort study
by: Forsyth, F, et al.
Published: (2021)

Derangement of cardiac high energy phosphate metabolism in patients with left ventricular non-compaction and preserved ejection fraction
by: Petersen, S, et al.
Published: (2006)

Use of cardiac magnetic resonance to detect changes in metabolism in heart failure
by: Watson, WD, et al.
Published: (2020)

Pirfenidone in heart failure with preserved ejection fraction—rationale and design of the PIROUETTE trial
by: Lewis, G, et al.
Published: (2019)

Characteristics of patients with heart failure with preserved ejection fraction in primary care: Cross-sectional analysis
by: Forsyth, F, et al.
Published: (2021)

Clinical and echocardiographic characteristics and cardiovascular outcomes according to diabetes status in patients with heart failure and preserved ejection fraction. A report from the Irbesartan in Heart Failure with Preserved Ejection Fraction trial (I-Preserve)
by: Kristensen, S, et al.
Published: (2017)

A comparison of visual and quantitative assessment of left ventricular ejection fraction by cardiac magnetic resonance
by: Holloway, C, et al.
Published: (2011)

A comparison of visual and quantitative assessment of left ventricular ejection fraction by cardiac magnetic resonance.
by: Holloway, C, et al.
Published: (2011)

Erratum to: A comparison of visual and quantitative assessment of left ventricular ejection fraction by cardiac magnetic resonance.
by: Holloway, C, et al.
Published: (2011)

Multiparametric cardiovascular magnetic resonance for the assessment of cardiac function and metabolism in hypertrophy and heart failure
by: Mahmod, M
Published: (2013)

Understanding the management of heart failure with preserved ejection fraction: a qualitative multiperspective study
by: Sowden, E, et al.
Published: (2020)

Risk Related to Pre–Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction
by: Kristensen, S, et al.
Published: (2016)

Impaired active relaxation during dynamic exercise in patients with heart failure with a preserved ejection fraction (HfpEF)
by: Phan, T, et al.
Published: (2008)

Phenogrouping heart failure with preserved or mildly reduced ejection fraction using electronic health record data
by: Soltani, F, et al.
Published: (2024)

A hyperdynamic RV is an early marker of clinical decompensation and cardiac recovery in aortic stenosis with normal LV ejection fraction
by: Rigolli, M, et al.
Published: (2018)

Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis
by: Kotecha, D, et al.
Published: (2016)

Using multi-parametric imaging and multi-nuclear cardiac magnetic resonance to investigate novel treatment strategies for heart failure
by: Hundertmark, MJ
Published: (2022)

Investigating cardiac energetics in heart failure.
by: Lygate, C, et al.
Published: (2013)

Investigating cardiac energetics in heart failure
by: Lygate, C, et al.
Published: (2013)

Effects of chronic beta-receptor blocker treatment on cardiac high-energy phosphate metabolism in heart failure
by: Neubauer, S
Published: (2000)

Cost Evaluation Of Heart Failure Treatment, Cost-effectiveness Analysis And Budget Impact Of Adding Empagliflozin To Standard Treatment For Heart Failure With Reduced Ejection Fraction
by: Low, Joo Zheng
Published: (2023)

Cardiac dysfunction and development of heart failure.
by: Ertl, G, et al.
Published: (1993)

DYNAMIC CHANGES IN LEFT VENTRICULAR FUNCTION ON EXERCISE IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: THE ROLE OF MYOCARDIAL ENERGY DEFICIENCY
by: Phan, T, et al.
Published: (2009)

Opposite correlations of cardiac palmitate oxidation rates and plasma free fatty acids with ejection fractions in the infarcted rat heart
by: Catchpole, A, et al.
Published: (2008)